Evidence map›Paper›PMID 34544476›Full record

ReviewEuropean journal of medical research2021

Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature.

Shuming Jiang, Jianfei E, Dengchao Wang, Yanjiao Zou, Xiao Liu, Hualiang Xiao, Yuan Wen, Zongyao Chen

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in European journal of medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Oncoimmunology · 2026
    Article
  3. Article
  4. Article
  5. Research square · 2026
    Article
  6. bioRxiv : the preprint server for biology · 2026
    Article
  7. Longitudinal associations between PMFrontiers in cellular and infection microbiology · 2026
    Article
  8. Clinical characteristics and antimicrobial susceptibility ofNagoya journal of medical science · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Bacterial pathogens in pediatric appendicitis: a comprehensive retrospective study.Frontiers in cellular and infection microbiology · 2023
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shuming Jiang *Pathology Department, People's Hospital of Deyang City, Deyang, China.
Jianfei E *Department of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
Dengchao WangDepartment of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
Yanjiao ZouDepartment of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
Xiao LiuDepartment of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
Hualiang XiaoDepartment of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
Yuan WenDepartment of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
Zongyao ChenDepartment of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China. chenzyao@yeah.net.ORCID http://orcid.org/0000-0002-4202-9579
Deyang Stomatological Hospital · CNFuyang City People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eggerthella lenta is a normal human microflora that is anaerobic, non-sporulating, and Gram positive. However, an increasing number of studies have shown that it could also be an important pathogen for humans, even causing life-threatening infection under certain conditions. However, understanding its pathogenic mechanism and treatment options still need to be improved; more clinical data are needed to explore it further. In this article, we report a case of ceftizoxime-cured E. lenta bacteremia and review the recent literature to provide more clinical data for the diagnosis of E. lenta bacteremia. Our report suggests that the frequency of E. lenta bacteremia is increased in patients with hematologic or solid organ cancer, diabetes mellitus and also in those with appendicitis.

Indexed as

ActinobacteriaAdultAnti-Bacterial AgentsBacteremiaCeftizoximeHumansMalePrognosisAnti-Bacterial AgentsCeftizoximeAppendicitisBacteremiaCeftizoximeEggerthella lenta

Identifiers

PMID34544476
PMCPMC8454090
OpenAlexW3201055976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.